Local Institution - 501

Rotterdam 3075 EA

0 studies enrolling now · 2 studies all time

What they study most

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Multiple Myeloma

Studies at this site

• A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma — Running, not enrolling
• A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia — Completed